AI-Enabled Medical Imaging Solutions Market Overview
The global AI-enabled medical imaging solutions market is estimated to reach $18,356.5 million in 2032, reveals the premium market intelligence study. The study also highlights that the market is set to witness a CAGR of 25.76% during the forecast period 2022-2032.
AI-based medical imaging solutions are a disruptive technology with great potential, and the market is anticipated to grow during the forecast period owing to increasing awareness regarding the early detection of chronic disorders, facilitation of better clinical decision-making, and increased accuracy with artificial intelligence.
USP of the Report
• Extensive product benchmarking on the basis of modality, workflow, and therapeutic applications of top players (including established and emerging players) to offer a holistic view of the global AI-enabled medical imaging solutions market.
• In depth key development analysis
• Regulatory framework and legal requirements for AI-enabled medical imaging solutions
• Clinical trials data for different therapeutic areas of AI-enabled imaging solutions
• Cross segmentation and market numbers on country level
• Key trends and opportunity assessment in the market
• Real world evidence based on different case studies
• Industry ecosystem along with list of FDA approved AI-enabled medical imaging solutions
• Market share analysis
• Funding Scenario
Analyst Perspective
According to Satyendrsingh Rajput, Lead Analyst of the report, “Artificial intelligence is fundamentally transforming the medical imaging industry, both in terms of diagnostic accuracy and productivity. Novel cognitive algorithms promise to offer several concrete prospects, such as quantitative imaging, prognostic risk assessment, unceasing treatment monitoring, and above all, utmost diagnostic accuracy. The market is anticipated to grow during the forecast period owing to increasing awareness regarding the early detection of chronic disorders, facilitation of better clinical decision-making, and increased accuracy with artificial intelligence.”
Key Companies Operating in The Market
Key players in the global AI-enabled medical imaging solutions market analyzed and profiled in the study involve players that offer AI-enabled medical imaging solutions. Moreover, a detailed product benchmarking based on workflow, modality, and therapeutic application of the players operating in the global AI-enabled medical imaging solutions market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, collaborations, product launches and approvals, and funding scenarios will aid the reader in understanding the untapped revenue pockets in the market.
The key players profiled in the report include Agfa-Gevaert Group, Aidoc, Blackford Analysis Limited, Butterfly Network, Inc., Canon Inc., Caption Health, Carestream Health Inc., FUJIFILM Holdings Corporation, General Electric Company, Hologic, Inc., iCAD, Inc., Koninklijke Philips N.V., NVIDIA Corporation, Siemens Healthineers AG, and VUNO, Inc.
Key Questions Answered in the Report/h3>
• What are the major market drivers, challenges, and opportunities in the global AI enabled medical imaging solutions market?
• What are the emerging trends within the global AI-enabled medical imaging solutions market?
• How is each product type of the global AI-enabled medical imaging solutions market expected to grow during the forecast period, and what is the anticipated
revenue generated by each of the products by the end of 2032?
• What is the growth potential of the global AI-enabled medical imaging solutions market in North America, Europe, Asia-Pacific, and the Rest-of-the-World (RoW)?
• What is the patent filing trend in the global AI-enabled medical imaging solutions market?
• What are some of the case studies in the global AI-enabled medical imaging solutions market?
• What is the market segmentation based on modality? How are the modalities ranked in terms of the level of AI-enabled medical imaging solutions?
• What is the market segmentation based on therapeutic application? How are the therapeutic applications ranked in terms of the level of AI-enabled medical imaging
solutions?
• How has the COVID-19 pandemic impacted the global AI-enabled medical imaging solutions market?